ProPhase Labs, Inc.
PRPH
$0.05
$0.0120.05%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.39M | 4.35M | 5.06M | 5.59M | 5.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.39M | 4.35M | 5.06M | 5.59M | 5.85M |
| Cost of Revenue | 2.37M | 2.96M | 4.07M | 4.26M | 5.41M |
| Gross Profit | 1.03M | 1.38M | 987.00K | 1.33M | 436.00K |
| SG&A Expenses | 18.00M | 19.32M | 30.43M | 32.37M | 34.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.38M | 22.39M | 34.67M | 36.92M | 40.51M |
| Operating Income | -16.99M | -18.05M | -29.61M | -31.33M | -34.66M |
| Income Before Tax | -22.69M | -23.39M | -34.38M | -34.86M | -38.92M |
| Income Tax Expenses | 1.37M | 0.00 | 15.18M | 12.83M | 9.76M |
| Earnings from Continuing Operations | -24.06 | -23.39 | -49.56 | -47.69 | -48.68 |
| Earnings from Discontinued Operations | 0.00 | 8.64M | 7.86M | 6.24M | 5.55M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.06M | -14.74M | -41.70M | -41.45M | -43.13M |
| EBIT | -16.99M | -18.05M | -29.61M | -31.33M | -34.66M |
| EBITDA | -12.68M | -13.22M | -24.22M | -25.45M | -28.60M |
| EPS Basic | -3.49 | -1.93 | -15.92 | -17.73 | -19.91 |
| Normalized Basic EPS | -1.92 | -2.49 | -7.10 | -8.46 | -10.63 |
| EPS Diluted | -3.52 | -1.96 | -15.98 | -17.79 | -19.95 |
| Normalized Diluted EPS | -1.92 | -2.49 | -7.10 | -8.46 | -10.63 |
| Average Basic Shares Outstanding | 42.74M | 33.95M | 14.23M | 11.98M | 9.72M |
| Average Diluted Shares Outstanding | 42.74M | 33.95M | 14.23M | 11.98M | 9.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |